Quantcast

Latest Intrexon Corporation Stories

2015-05-11 16:33:52

- Net income of $27.1 million or $0.26 per basic share - GERMANTOWN, Md., May 11, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its first

2015-05-04 08:23:27

GERMANTOWN, Md., May 4, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON) today announced it will release first quarter 2015

2015-04-30 08:41:16

GERMANTOWN, Md., April 30, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced

2015-04-20 08:31:06

Healthy Produce Choices for Consumers With Benefits Across Entire Supply Chain GERMANTOWN, Md., April 20, 2015 /PRNewswire/ -- Intrexon

2015-04-15 08:25:35

Intrexon and FuturaGene Collaborate to Develop Unique Attributes and Agronomic Properties in Significant Plant Species GERMANTOWN, Md.

2015-04-01 16:28:29

GERMANTOWN, Md., April 1, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced

2015-03-30 08:31:10

- Chimeric Antigen Receptor T-cell (CAR-T) therapy enhances Merck Serono's R&D technology portfolio in immuno-oncology GERMANTOWN, Md., March 30, 2015 /PRNewswire/ --

2015-03-30 08:30:57

- Chimeric Antigen Receptor T-cell (CAR-T) therapy enhances R&D technology portfolio of Merck KGaA, Darmstadt, Germany, in immuno-oncology DARMSTADT, Germany, March 30, 2015 /PRNewswire/

2015-03-30 08:30:54

-- Chimeric Antigen Receptor T-cell (CAR-T) therapy enhances Merck Serono's R&D technology portfolio in immuno-oncology DARMSTADT, Germany, March 30, 2015 /PRNewswire/ -- Merck Serono,

2015-03-02 16:30:22

Quarterly Net Income of $18.8M or $0.19/share on 335% Revenue Growth GERMANTOWN, Md., March 2, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced


Word of the Day
logocentrism
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.
Related